Company intelligence / Profile preview

RecoverLINK

Ownership: Private
Development stage: Commercial

Overview

RecoverLINK has developed a mobile health technology platform that supports heart failure patients after hospital discharge. The solution aims to transform the post-discharge experience by providing digital tools for monitoring and engagement. It is women-founded and has received recognition in entrepreneurial competitions, including a $75,000 award at NYU Stern's Entrepreneurs Challenge in 2014–2015. No clinical trial results are referenced; the product appears to be commercially deployed.

Therapeutic areas: Cardiovascular
Modalities: Non-pharmacological therapy (Digital health intervention)
Industry: Digital Health Medical Devices

Partnerships

No major pharmaceutical or biotech partnerships identified.

Beyond the preview

Go deeper on RecoverLINK.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RecoverLINK.

Explore the full profile